Xiang Liao
Direktor/Vorstandsmitglied bei CLOVER BIOPHARMACEUTICALS, LTD.
Vermögen: 13 266 $ am 30.04.2024
Profil
Xiang Liao is currently the Chief Executive Officer at Novastream Biotech Co. Ltd.
and an Independent Non-Executive Director at Clover Biopharmaceuticals Ltd.
Previously, he worked as the Director of Corporate Development at Sanofi Pasteur from 1992 to 2007.
Mr. Liao holds an MBA from The Trustees of Columbia University in The City of New York, a graduate degree from the University of Scranton, and an undergraduate degree from West China University of Medical Sciences.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
02.04.2024 | 300 750 ( 0,02% ) | 13 266 $ | 30.04.2024 |
Aktive Positionen von Xiang Liao
Unternehmen | Position | Beginn |
---|---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Direktor/Vorstandsmitglied | 19.04.2021 |
Novastream Biotech Co. Ltd. | Vorstandsvorsitzender | 01.03.2012 |
Ehemalige bekannte Positionen von Xiang Liao
Unternehmen | Position | Ende |
---|---|---|
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Corporate Officer/Principal | 01.12.2007 |
Ausbildung von Xiang Liao
West China University of Medical Sciences | Undergraduate Degree |
University of Scranton | Graduate Degree |
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Novastream Biotech Co. Ltd. | |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |